Aclaris: Q2 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Monday reported a loss of $29.6 million in its second quarter.

On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of 42 cents.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The specialty pharmaceutical company posted revenue of $1.9 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $1.7 million.

Aclaris shares have fallen 37% since the beginning of the year. The stock has fallen 45% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS

Advertisement

Recommended Stories